OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,738.15
-51.9 (-2.9%)
BSENSE

Jun 08, 03:30 PM

BSE+NSE Vol: 2.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Rubicon Research
Neuland Labs.
Granules India
Sai Life
Natco Pharma
OneSource Speci.
ERIS Lifescience
Astrazeneca Phar
Piramal Pharma
Pfizer
Cohance Life

Why is OneSource Specialty Pharma Ltd ?

1
Poor Management Efficiency with a low ROE of 0.80%
  • The company has been able to generate a Return on Equity (avg) of 0.80% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.68
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.68
  • The company has been able to generate a Return on Equity (avg) of 0.80% signifying low profitability per unit of shareholders funds
3
Healthy long term growth as Net Sales has grown by an annual rate of 185.90% and Operating profit at 67.54%
4
Flat results in Mar 26
  • PAT(Q) At Rs 4.57 cr has Fallen at -40.6% (vs previous 4Q average)
5
With ROCE of 0.3, it has a Very Expensive valuation with a 3 Enterprise value to Capital Employed
  • Over the past year, while the stock has generated a return of -10.55%, its profits have fallen by -80%
6
38.38% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
  • The proportion of pledged holdings has increased by 19.86% over the last quarter
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to OneSource Speci. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is OneSource Speci. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
OneSource Speci.
-10.55%
-0.23
45.40%
Sensex
-10.54%
-0.81
13.06%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
185.90%
EBIT Growth (5y)
67.54%
EBIT to Interest (avg)
0.68
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.18
Tax Ratio
19.74%
Dividend Payout Ratio
0
Pledged Shares
38.38%
Institutional Holding
38.11%
ROCE (avg)
-5.29%
ROE (avg)
0.80%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
3.51
EV to EBIT
871.55
EV to EBITDA
71.97
EV to Capital Employed
3.03
EV to Sales
15.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.35%
ROE (Latest)
-1.10%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(Q)

Highest at Rs 428.22 cr

-4What is not working for the Company
PAT(Q)

At Rs 4.57 cr has Fallen at -40.6% (vs previous 4Q average

Loading Valuation Snapshot...

Here's what is working for OneSource Speci.

Net Sales - Quarterly
Highest at Rs 428.22 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 428.22 cr has Grown at 20.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 354.83 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for OneSource Speci.

Profit After Tax (PAT) - Quarterly
At Rs 4.57 cr has Fallen at -40.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 7.69 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)